Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.16), versus ($0.19) reported last year. Revenue for the quarter came in at $97 thousand, versus $367 thousand reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.